These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 19814736)

  • 1. Clinical and laboratory phenotype associated with the aspirin-like defect.
    Dragani A; Brancati F; Pascale S; Mattoscio D; Rocca B
    Br J Haematol; 2010 Feb; 148(4):661-3; author reply 663-4. PubMed ID: 19814736
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and laboratory phenotypes associated with the aspirin-like defect: a study in 17 unrelated families.
    Rolf N; Knoefler R; Bugert P; Gehrisch S; Siegert G; Kuhlisch E; Suttorp M
    Br J Haematol; 2009 Feb; 144(3):416-24. PubMed ID: 19036102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiplatelet therapy can unmask an inherited bleeding disorder. Aspirin-like defect of platelets does not protect against atherosclerosis].
    Elikowski W; Hanszke E; Biczysko W; Rzeźniczak J; Kruk-Zagajewska A; Zawilska K
    Kardiol Pol; 2007 Aug; 65(8):985-91; discussion 992-3. PubMed ID: 17853322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombocyte aggregation and serum thromboxane in patients with acute myocardial infarction].
    Midttun M; Grauholt AM; Grande P
    Ugeskr Laeger; 1990 Dec; 153(1):25-6. PubMed ID: 2275044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of PAF on the metabolization of arachidonic acid by human blood platelets.
    Ostermann G; Block HU; Till U
    Biomed Biochim Acta; 1984; 43(8-9):S323-6. PubMed ID: 6440547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
    Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD
    Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose- and time-dependent antiplatelet effects of aspirin.
    Perneby C; Wallén NH; Rooney C; Fitzgerald D; Hjemdahl P
    Thromb Haemost; 2006 Apr; 95(4):652-8. PubMed ID: 16601836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
    J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma arachidonic acid and serum thromboxane B2 concentrations in phenylketonuric children are correlated with dietary compliance.
    Agostoni C; Riva E; Galli C; Marangoni F; Luotti D; Giovannini M
    Z Ernahrungswiss; 1998; 37 Suppl 1():122-4. PubMed ID: 9558743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined arachidonic acid and ADP platelet inhibition maximizes patency of small-diameter vascular grafts.
    Valentin LI; Sicard GA; Freeman MB; Allen BT; McGoff MA; Anderson CB
    Surgery; 1988 Aug; 104(2):178-84. PubMed ID: 3135624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of thiofedrine on platelet aggregation, thromboxane B2 and 6-keto-PGF1 alpha in rats.
    Qu YZ; Wang YE; Li XX
    Methods Find Exp Clin Pharmacol; 1996 Jun; 18(5):297-300. PubMed ID: 8817463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of anethole dithiolthione on human platelet aggregation.
    Selley ML; McGuiness JA; Bartlett MR; Ardlie NG
    Arzneimittelforschung; 1992 Mar; 42(3):318-21. PubMed ID: 1497692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of low-dose acetylsalicylic acid on thrombocytes in health subjects and in patients with coronary heart disease].
    Terres W; Schuster O; Kupper W; Bleifeld W
    Dtsch Med Wochenschr; 1989 Aug; 114(33):1231-6. PubMed ID: 2504574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of insulin antibodies, platelet-fixing immune complexes and platelet-associated IgG to in vitro platelet aggregation and thromboxane B2 synthesis in childhood type 1 (insulin-dependent) diabetes mellitus.
    Triolo G; Davì G; Giardina E; Cardella F; Meli F; Strano A; Bompiani GD
    Diabetes Res; 1989 Jan; 10(1):1-5. PubMed ID: 2503285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin.
    Pettinella C; Romano M; Stuppia L; Santilli F; Liani R; Davì G
    Thromb Haemost; 2009 Apr; 101(4):687-90. PubMed ID: 19350112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and laboratory aspects of the Aspirin-like defect as hereditary thrombocytopathy].
    Rolf N; Bugert P; Gehrisch S; Siegert G; Suttorp M; Knöfler R
    Hamostaseologie; 2009 May; 29(2):177-83. PubMed ID: 19404514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding time in rats: a comparison of different experimental conditions.
    Dejana E; Villa S; de Gaetano G
    Thromb Haemost; 1982 Aug; 48(1):108-11. PubMed ID: 6753230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.